Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Feb 15, 2019; 11(2): 139-152
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.139
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.139
Table 6 Relative increase in risk of death in unit changes of determined variables
Significance level (P) | Relative increase in risk of death according to unit change (fold) | 95%CI | ||
Lower limit | Upper limit | |||
Age (yr) | 0.041 | 1.04 | 1.007 | 1.066 |
Gender (M/F) | 0.015 | 2.0 | 1.028 | 3.976 |
Tumor diameter (cm) | 0.02 | 1.09 | 1.014 | 1.169 |
Tumor grade (Ki-67) (3/1-2) | < 0.001 | 3.6 | 1.873 | 7.206 |
Tumor grade (mitosis) (3/1-2) | 0.006 | 3.0 | 2.823 | 13.362 |
Determined tumor grade (3/1-2) | < 0.001 | 3.6 | 1.873 | 7.206 |
Tumor stage (3-4/1-2) | < 0.001 | 12.7 | 3.869 | 41.708 |
CRP level (mg/L ) | 0.005 | 1.01 | 1.022 | 1.253 |
Liver metastasis (P/A) | < 0.001 | 6.1 | 2.823 | 13.362 |
- Citation: Komaç Ö, Bengi G, Sağol Ö, Akarsu M. C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumor group. World J Gastrointest Oncol 2019; 11(2): 139-152
- URL: https://www.wjgnet.com/1948-5204/full/v11/i2/139.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i2.139